Skip to content

Evaluation of Transnasal Endoscopy During COVID-19 Pandemic

Evaluation of Transnasal Endoscopy During COVID-19 Pandemic

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04734912
Enrollment
500
Registered
2021-02-02
Start date
2021-01-13
Completion date
2021-12-31
Last updated
2021-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endoscopy

Keywords

gastroscopy, transnasal, nursing

Brief summary

Patients who received the indication for endoscopic diagnostics using gastroscopy in transnasal technique will be included into the study. The examination is carried out in standard technique and is not influenced by the study. Following the examination, patient data is collected pseudonymously and a questionnaire is submitted to the patient.

Detailed description

COVID-19 is transmitted, among other things, by a droplet infection. Conventional gastroscopy through the patient's mouth is therefore considered a high-risk examination for the medical and nursing staff. Alternatively, gastroscopy can also be performed through the patient's nose. An advantage here is that the aerosol formation is naturally significantly reduced and the patient usually does not need sedation, since in transnasal endoscopy no stranglehold occurs. Transnasal endoscopy therefore appears to us, especially during the COVID-19 pandemic, as a safe alternative to conventional gastroscopy. Patients who received the indication for endoscopic diagnostics using gastroscopy in transnasal technique will be included into the study. The examination is carried out in standard technique and is not influenced by the study. Following the examination, patient data is collected pseudonymously and a questionnaire is sumbitted to the patient. Only patients who have the indication for gastroscopy in transnasal technique are included. A specific risk to patients cannot be foreseen.This study does not interfere with diagnostics or therapy.

Interventions

OTHERgastroscopy in transnasal techique

All patients with indication for gastroscopy in transnasal technique are included.

Sponsors

Johannes Gutenberg University Mainz
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

all patients with indication für gastroscopy in transnasal techique are included.

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Indication for transnasal endoscopy

Exclusion criteria

* pregnancy * breast feeding * contraindication to transnasal endoscopy * pronounced blood clotting disorders

Design outcomes

Primary

MeasureTime frameDescription
Questionnaireafter examination, about 15 minutesa questionnaire with 5 questions regarding the quality of the examination, technique and safety is presented to the patients

Countries

Germany

Contacts

Primary ContactHelmut Neumann, M.D. PhD
helmut.neumann@unimedizin-mainz.de+49 (0) 6131
Backup ContactTanja Bender, M.A.
tanja.bender@unimedizin-mainz.de+49 (0) 6131

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026